99 related articles for article (PubMed ID: 19720942)
1. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
Westerink J; Visseren FL
Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942
[No Abstract] [Full Text] [Related]
2. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
Settergren M; Rydén L; Pernow J
Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944
[No Abstract] [Full Text] [Related]
3. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
Tershakovec AM; Veltri EP; Pasternak RC
Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943
[No Abstract] [Full Text] [Related]
4. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.
Liu PY; Liu YW; Lin LJ; Chen JH; Liao JK
Circulation; 2009 Jan; 119(1):131-8. PubMed ID: 19075102
[TBL] [Abstract][Full Text] [Related]
5. [How sure is the combined lipid lowering?].
Schäfer J
MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.
Quarta CC; Potena L; Grigioni F; Scalone A; Magnani G; Coccolo F; Fallani F; Russo A; Branzi A
J Heart Lung Transplant; 2008 Jun; 27(6):685-8. PubMed ID: 18503971
[TBL] [Abstract][Full Text] [Related]
7. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
Farmer JA
Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479
[No Abstract] [Full Text] [Related]
8. [Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia].
Sumarokov AB; Kukharchuk VV
Ter Arkh; 2014; 86(12):107-15. PubMed ID: 25804051
[TBL] [Abstract][Full Text] [Related]
9. Utility of ezetimibe.
Ashikaga H; Blumenthal RS; Jones SR
Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
[No Abstract] [Full Text] [Related]
10. How to use ezetimibe as an anti-atherogenic agent via inhibition of Rho-kinase.
Noma K; Higashi Y
Circ J; 2012; 76(8):1836-7. PubMed ID: 22785339
[No Abstract] [Full Text] [Related]
11. Ezetimibe improves endothelial function and inhibits Rho-kinase activity associated with inhibition of cholesterol absorption in humans.
Nochioka K; Tanaka S; Miura M; Zhulanqiqige do E; Fukumoto Y; Shiba N; Shimokawa H
Circ J; 2012; 76(8):2023-30. PubMed ID: 22640986
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
Rodríguez-Ferrero ML; Anaya F
Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
[TBL] [Abstract][Full Text] [Related]
14. Enhanced hype.
Harrison DG; Brown WV; Raggi P
Am J Cardiol; 2008 Aug; 102(3):368-9. PubMed ID: 18638604
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
Spence JD
Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481
[No Abstract] [Full Text] [Related]
16. Case reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapy.
Robins DN
J Drugs Dermatol; 2007 Sep; 6(9):946-7. PubMed ID: 17941369
[TBL] [Abstract][Full Text] [Related]
17. Ezetimibe coadministered with fenofibrate: some safety questions.
Borja J
Eur Heart J; 2005 Nov; 26(21):2344; author reply 2344. PubMed ID: 16123048
[No Abstract] [Full Text] [Related]
18. PANACEA or much a do about nothing: effect of a statin and ezetimibe on postprandial lipaemia and endothelial function in the metabolic syndrome.
Chan DC; Watts GF
Atherosclerosis; 2013 Mar; 227(1):32-4. PubMed ID: 23321395
[No Abstract] [Full Text] [Related]
19. Comment on: Clinical benefits of ezetimibe: absence of proof is just that.
Doggrell SA
Expert Opin Pharmacother; 2013 Dec; 14(18):2611-2. PubMed ID: 24160556
[No Abstract] [Full Text] [Related]
20. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
Gouni-Berthold I; Mikhailidis DP; Rizzo M
Expert Opin Pharmacother; 2012 Oct; 13(14):1985-8. PubMed ID: 22946714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
